117 related articles for article (PubMed ID: 36993747)
1. Unexpected inhibition of the lipid kinase PIKfyve reveals an epistatic role for p38 MAPKs in endolysosomal fission and volume control.
Wible DJ; Parikh Z; Cho EJ; Chen MD; Mukhopadhyay S; Dalby KN; Varadarajan S; Bratton SB
bioRxiv; 2023 Mar; ():. PubMed ID: 36993747
[TBL] [Abstract][Full Text] [Related]
2. Unexpected inhibition of the lipid kinase PIKfyve reveals an epistatic role for p38 MAPKs in endolysosomal fission and volume control.
Wible DJ; Parikh Z; Cho EJ; Chen MD; Jeter CR; Mukhopadhyay S; Dalby KN; Varadarajan S; Bratton SB
Cell Death Dis; 2024 Jan; 15(1):80. PubMed ID: 38253602
[TBL] [Abstract][Full Text] [Related]
3. Active vacuolar H+ ATPase and functional cycle of Rab5 are required for the vacuolation defect triggered by PtdIns(3,5)P2 loss under PIKfyve or Vps34 deficiency.
Compton LM; Ikonomov OC; Sbrissa D; Garg P; Shisheva A
Am J Physiol Cell Physiol; 2016 Sep; 311(3):C366-77. PubMed ID: 27335171
[TBL] [Abstract][Full Text] [Related]
4. SB202190-induced cell type-specific vacuole formation and defective autophagy do not depend on p38 MAP kinase inhibition.
Menon MB; Kotlyarov A; Gaestel M
PLoS One; 2011; 6(8):e23054. PubMed ID: 21853067
[TBL] [Abstract][Full Text] [Related]
5. Class III PI 3-kinase is the main source of PtdIns3P substrate and membrane recruitment signal for PIKfyve constitutive function in podocyte endomembrane homeostasis.
Ikonomov OC; Sbrissa D; Venkatareddy M; Tisdale E; Garg P; Shisheva A
Biochim Biophys Acta; 2015 May; 1853(5):1240-50. PubMed ID: 25619930
[TBL] [Abstract][Full Text] [Related]
6. PIKfyve inhibitor cytotoxicity requires AKT suppression and excessive cytoplasmic vacuolation.
Ikonomov OC; Altankov G; Sbrissa D; Shisheva A
Toxicol Appl Pharmacol; 2018 Oct; 356():151-158. PubMed ID: 30098992
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of lipid kinase PIKfyve reveals a role for phosphatase Inpp4b in the regulation of PI(3)P-mediated lysosome dynamics through VPS34 activity.
Saffi GT; Wang CA; Mangialardi EM; Vacher J; Botelho RJ; Salmena L
J Biol Chem; 2022 Aug; 298(8):102187. PubMed ID: 35760104
[TBL] [Abstract][Full Text] [Related]
8. Distinct Requirements for Vacuolar Protein Sorting 34 Downstream Effector Phosphatidylinositol 3-Phosphate 5-Kinase in Podocytes Versus Proximal Tubular Cells.
Venkatareddy M; Verma R; Kalinowski A; Patel SR; Shisheva A; Garg P
J Am Soc Nephrol; 2016 Sep; 27(9):2702-19. PubMed ID: 26825532
[TBL] [Abstract][Full Text] [Related]
9. Apilimod, a candidate anticancer therapeutic, arrests not only PtdIns(3,5)P2 but also PtdIns5P synthesis by PIKfyve and induces bafilomycin A1-reversible aberrant endomembrane dilation.
Sbrissa D; Naisan G; Ikonomov OC; Shisheva A
PLoS One; 2018; 13(9):e0204532. PubMed ID: 30240452
[TBL] [Abstract][Full Text] [Related]
10. PIP5K1C phosphoinositide kinase deficiency distinguishes PIKFYVE-dependent cancer cells from non-malignant cells.
Roy A; Chakraborty AR; Nomanbhoy T; DePamphilis ML
Autophagy; 2023 Sep; 19(9):2464-2484. PubMed ID: 36803256
[TBL] [Abstract][Full Text] [Related]
11. Functional dissociation between PIKfyve-synthesized PtdIns5P and PtdIns(3,5)P2 by means of the PIKfyve inhibitor YM201636.
Sbrissa D; Ikonomov OC; Filios C; Delvecchio K; Shisheva A
Am J Physiol Cell Physiol; 2012 Aug; 303(4):C436-46. PubMed ID: 22621786
[TBL] [Abstract][Full Text] [Related]
12. Akebia saponin E, as a novel PIKfyve inhibitor, induces lysosome-associated cytoplasmic vacuolation to inhibit proliferation of hepatocellular carcinoma cells.
Peng P; Jia D; Cao L; Lu W; Liu X; Liang C; Pan Z; Fang Z
J Ethnopharmacol; 2021 Feb; 266():113446. PubMed ID: 33031902
[TBL] [Abstract][Full Text] [Related]
13. Stimulation of MAPK cascades by insulin and osmotic shock: lack of an involvement of p38 mitogen-activated protein kinase in glucose transport in 3T3-L1 adipocytes.
Kayali AG; Austin DA; Webster NJ
Diabetes; 2000 Nov; 49(11):1783-93. PubMed ID: 11078444
[TBL] [Abstract][Full Text] [Related]
14. The Lysosomal Storage Disorder Due to
Bao W; Wang X; Luo L; Ni R
Zebrafish; 2021 Jun; 18(3):175-183. PubMed ID: 33909505
[TBL] [Abstract][Full Text] [Related]
15. PIKfyve accelerates phagosome acidification through activation of TRPML1 while arrests aberrant vacuolation independent of the Ca2+ channel.
Isobe Y; Nigorikawa K; Tsurumi G; Takemasu S; Takasuga S; Kofuji S; Hazeki K
J Biochem; 2019 Jan; 165(1):75-84. PubMed ID: 30295876
[TBL] [Abstract][Full Text] [Related]
16. PIKfyve Kinase and SKD1 AAA ATPase define distinct endocytic compartments. Only PIKfyve expression inhibits the cell-vacoulating activity of Helicobacter pylori VacA toxin.
Ikonomov OC; Sbrissa D; Yoshimori T; Cover TL; Shisheva A
J Biol Chem; 2002 Nov; 277(48):46785-90. PubMed ID: 12213828
[TBL] [Abstract][Full Text] [Related]
17. PIKfyve regulation of endosome-linked pathways.
de Lartigue J; Polson H; Feldman M; Shokat K; Tooze SA; Urbé S; Clague MJ
Traffic; 2009 Jul; 10(7):883-93. PubMed ID: 19582903
[TBL] [Abstract][Full Text] [Related]
18. Snx10 and PIKfyve are required for lysosome formation in osteoclasts.
Sultana F; Morse LR; Picotto G; Liu W; Jha PK; Odgren PR; Battaglino RA
J Cell Biochem; 2020 Apr; 121(4):2927-2937. PubMed ID: 31692073
[TBL] [Abstract][Full Text] [Related]
19. Intermittent inhibition of FYVE finger-containing phosphoinositide kinase induces melanosome degradation in B16F10 melanoma cells.
Kawaguchi K; Watanabe M; Furukawa S; Koga K; Kanamori H; Ikemoto MJ; Takashima S; Maeda M; Oh-Hashi K; Hirata Y; Furuta K; Takemori H
Mol Biol Rep; 2023 Jul; 50(7):5917-5930. PubMed ID: 37248430
[TBL] [Abstract][Full Text] [Related]
20. Activation of c-Jun N-terminal kinase (JNK) by widely used specific p38 MAPK inhibitors SB202190 and SB203580: a MLK-3-MKK7-dependent mechanism.
Muniyappa H; Das KC
Cell Signal; 2008 Apr; 20(4):675-83. PubMed ID: 18222647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]